European cardiovascular magnetic resonance (EuroCMR) registry – multi national results from 57 centers in 15 countries
暂无分享,去创建一个
E. Nagel | S. Petersen | A. van Rossum | M. Lombardi | S. Schneider | A. Wagner | H. Frank | G. Pilz | H. Mahrholdt | S. Prasad | P. Monney | J. Schwitter | H. Steen | T. Dill | O. Bruder | G. Sabin | D. Nothnagel | J. Schumm | S. Greulich | A. Cagnolo | Christina Deluigi | A. V. van Rossum | Detlev Nothnagel | S. Prasad
[1] D. Chew,et al. Prognostic value of adenosine stress perfusion cardiac MRI with late gadolinium enhancement in an intermediate cardiovascular risk population. , 2013, International journal of cardiology.
[2] E. Nagel,et al. European Cardiovascular Magnetic Resonance (EuroCMR) registry - multi national tesults from 57 centers in 15 countries , 2013, Journal of Cardiovascular Magnetic Resonance.
[3] Massimo Lombardi,et al. Cost evaluation of cardiovascular magnetic resonance versus coronary angiography for the diagnostic work-up of coronary artery disease: Application of the European Cardiovascular Magnetic Resonance registry data to the German, United Kingdom, Swiss, and United States health care systems , 2012, Journal of Cardiovascular Magnetic Resonance.
[4] S. Schneider,et al. Comparison of exercise electrocardiography and stress perfusion CMR for the detection of coronary artery disease in women , 2012, Journal of Cardiovascular Magnetic Resonance.
[5] C. Kramer,et al. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. , 2012, JACC. Cardiovascular imaging.
[6] S. Plein,et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial , 2012, The Lancet.
[7] E. Wellnhofer,et al. Long-term prognostic value of dobutamine stress CMR. , 2011, JACC. Cardiovascular imaging.
[8] M. Cheitlin,et al. Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy , 2011 .
[9] M. Sheppard,et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .
[10] E. Nagel,et al. Current variables, definitions and endpoints of the European Cardiovascular Magnetic Resonance Registry , 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[11] E. Nagel,et al. EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. , 2009, Journal of the American College of Cardiology.
[12] Jonathan Chan,et al. Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. , 2008, European heart journal.
[13] N. Paul,et al. Perioperative β-Blockers : Use With Caution Perioperative β Blockers in Patients Having Non-Cardiac Surgery : A Meta-Analysis , 2010 .
[14] M. Budoff,et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Indi , 2008, Journal of the American College of Cardiology.
[15] E. Nagel,et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[16] M. Robson,et al. Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. , 2007, Journal of the American College of Cardiology.
[17] Sebastian Kelle,et al. Prognostic Value of Cardiac Magnetic Resonance Stress Tests: Adenosine Stress Perfusion and Dobutamine Stress Wall Motion Imaging , 2007, Circulation.
[18] K. Klingel,et al. Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.
[19] Manesh R. Patel,et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group. , 2006, Journal of the American College of Radiology : JACR.
[20] E. Picano,et al. Safety of stress echocardiography (from the International Stress Echo Complication Registry). , 2006, The American journal of cardiology.
[21] Roger B. Davis,et al. Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.
[22] Igor Klem,et al. mproved Detection of Coronary rtery Disease by Stress Perfusion ardiovascular Magnetic Resonance With he Use of Delayed Enhancement Infarction Imaging , 2006 .
[23] James C Carr,et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Ra , 2006, Journal of the American College of Cardiology.
[24] R. Kim,et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.
[25] R. Fimmers,et al. Coronary MR angiography at 3.0 T versus that at 1.5 T: initial results in patients suspected of having coronary artery disease. , 2005, Radiology.
[26] Udo Sechtem,et al. Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.
[27] R. Kim,et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study , 2003, The Lancet.
[28] Thomas H. Lee,et al. Noninvasive Tests in Patients with Stable Coronary Artery Disease , 2001 .
[29] R. Kim,et al. Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation , 2001, Circulation.
[30] C. Boucher,et al. Clinical practice. Noninvasive tests in patients with stable coronary artery disease. , 2001, The New England journal of medicine.
[31] O. Simonetti,et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.
[32] O Strohm,et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. , 1998, Circulation.
[33] N. Gupta,et al. Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging. The GE SPECT Multicenter Adenosine Study Group. , 1992, Journal of the American College of Cardiology.
[34] D. Berman,et al. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability. , 1990, The American journal of cardiology.